Outcomes and safety of atezolizumab plus bevacizumab in the treatment of hepatocellular carcinoma: treatment prognosis and comparison with tyrosine kinase inhibitors in a French multicenter matched real-life study.

Details

Language :

English

ISSN :

0954691X

Volume :

36

Issue :

11

Database :

Complementary Index

Journal :

European Journal of Gastroenterology & Hepatology

Publication Type :

Academic Journal

Accession number :

180477629

Full Text :

https://doi.org/10.1097/MEG.0000000000002830